Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

James W. Vardiman

TitleEmeritus/Emerita
InstitutionUniversity of Chicago
DepartmentPathology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ahmed A, Aragao AP, Mudaliar K, Wilcox R, Vardiman J, Anastasi J, Mirza K. The Conundrum of Diagnosing Cutaneous Composite Lymphoma in the Molecular Age. Am J Dermatopathol. 2019 Oct; 41(10):757-766. PMID: 30973519.
      View in: PubMed
    2. Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, Larson RA, He C, Le Beau MM, Vardiman JW. Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018 06 06; 9(1):2286. PMID: 29875356.
      View in: PubMed
    3. Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJM, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 2018 04 10; 9:16192. PMID: 29633759.
      View in: PubMed
    4. Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, Larson RA, He C, Le Beau MM, Vardiman JW. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018 03 21; 9(1):1163. PMID: 29563491.
      View in: PubMed
    5. Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW. Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017 Oct; 141(10):1342-1393. PMID: 28225303.
      View in: PubMed
    6. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405. PMID: 27069254.
      View in: PubMed
    7. Vasanthakumar A, Arnovitz S, Marquez R, Lepore J, Rafidi G, Asom A, Weatherly M, Davis EM, Neistadt B, Duszynski R, Vardiman JW, Le Beau MM, Godley LA, Churpek JE. Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice. Blood. 2016 Jan 21; 127(3):310-3. PMID: 26644450.
      View in: PubMed
    8. Vardiman J, Reichard K. Acute Myeloid Leukemia With Myelodysplasia-Related Changes. Am J Clin Pathol. 2015 Jul; 144(1):29-43. PMID: 26071460.
      View in: PubMed
    9. McGregor S, Shah A, Raca G, Mirza MK, Smith SM, Anastasi J, Vardiman JW, Hyjek E, Gurbuxani S. PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-a rearrangement. Blood. 2014 Apr 24; 123(17):2742-3. PMID: 24764561.
      View in: PubMed
    10. Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, Tiu RV, Karafa M, Hsi ED. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9. PMID: 24463215.
      View in: PubMed
    11. Zhang X, Hyjek E, Vardiman J. A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. Am J Clin Pathol. 2013 May; 139(5):622-32. PMID: 23596114.
      View in: PubMed
    12. Cheng JX, Anastasi J, Watanabe K, Kleinbrink EL, Grimley E, Knibbs R, Shen QJ, Vardiman JW. Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome. Leukemia. 2013 Jun; 27(6):1291-300. PMID: 23411464.
      View in: PubMed
    13. Vardiman J. The classification of MDS: from FAB to WHO and beyond. Leuk Res. 2012 Dec; 36(12):1453-8. PMID: 22940257.
      View in: PubMed
    14. Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M, Westervelt P, Marcucci G, DeAngelo DJ, Vardiman JW, McDonnell D, Mrózek K, Bloomfield CD, Larson RA. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer. 2013 Jan 01; 119(1):90-8. PMID: 22744771.
      View in: PubMed
    15. Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJM, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 2012 Feb 21; 3:688. PMID: 22353710.
      View in: PubMed
    16. Hyjek E, Vardiman JW. Myelodysplastic/myeloproliferative neoplasms. Semin Diagn Pathol. 2011 Nov; 28(4):283-97. PMID: 22195406.
      View in: PubMed
    17. Porwit A, Vardiman JW. Acute myeloid leukemia with expanded erythropoiesis. Haematologica. 2011 Sep; 96(9):1241-3. PMID: 21880638.
      View in: PubMed
    18. Vardiman J, Hyjek E. World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants. Hematology Am Soc Hematol Educ Program. 2011; 2011:250-6. PMID: 22160042.
      View in: PubMed
    19. Mesa RA, Green A, Barosi G, Verstovsek S, Vardiman J, Gale RP. MPN-associated myelofibrosis (MPN-MF). Leuk Res. 2011 Jan; 35(1):12-3. PMID: 20684988.
      View in: PubMed
    20. Kolitz JE, George SL, Marcucci G, Vij R, Powell BL, Allen SL, DeAngelo DJ, Shea TC, Stock W, Baer MR, Hars V, Maharry K, Hoke E, Vardiman JW, Bloomfield CD, Larson RA. P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. Blood. 2010 Sep 02; 116(9):1413-21. PMID: 20522709.
      View in: PubMed
    21. Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009 Nov 05; 361(19):1872-85. PMID: 19890130.
      View in: PubMed
    22. Thiele J, Kvasnicka HM, Vardiman JW, Orazi A, Franco V, Gisslinger H, Birgegard G, Griesshammer M, Tefferi A. Bone marrow fibrosis and diagnosis of essential thrombocythemia. J Clin Oncol. 2009 Dec 01; 27(34):e220-1; author reply e222-3. PMID: 19858378.
      View in: PubMed
    23. Vardiman JW. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010 Mar 19; 184(1-2):16-20. PMID: 19857474.
      View in: PubMed
    24. Tefferi A, Skoda R, Vardiman JW. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009 Nov; 6(11):627-37. PMID: 19806146.
      View in: PubMed
    25. Tefferi A, Thiele J, Vardiman JW. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009 Sep 01; 115(17):3842-7. PMID: 19472396.
      View in: PubMed
    26. Tefferi A, Verstovsek S, Barosi G, Passamonti F, Roboz GJ, Gisslinger H, Paquette RL, Cervantes F, Rivera CE, Deeg HJ, Thiele J, Kvasnicka HM, Vardiman JW, Zhang Y, Bekele BN, Mesa RA, Gale RP, Kantarjian HM. Pomalidomide is active in the treatment of anemia associated with myelofibrosis. J Clin Oncol. 2009 Sep 20; 27(27):4563-9. PMID: 19652059.
      View in: PubMed
    27. Vardiman JW. Chronic myelogenous leukemia, BCR-ABL1+. Am J Clin Pathol. 2009 Aug; 132(2):250-60. PMID: 19605820.
      View in: PubMed
    28. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51. PMID: 19357394.
      View in: PubMed
    29. Grinblatt DL, Yu D, Hars V, Vardiman JW, Powell BL, Nattam S, Silverman LR, de Castro C, Stone RM, Bloomfield CD, Larson RA. Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803). Cancer. 2009 Jan 01; 115(1):84-93. PMID: 19025972.
      View in: PubMed
    30. Ozer O, Zhao YD, Ostler KR, Akin C, Anastasi J, Vardiman JW, Godley LA. The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells. Leuk Lymphoma. 2008 Aug; 49(8):1567-77. PMID: 18766971.
      View in: PubMed
    31. Stock W, La M, Sanford B, Bloomfield CD, Vardiman JW, Gaynon P, Larson RA, Nachman J. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008 Sep 01; 112(5):1646-54. PMID: 18502832.
      View in: PubMed
    32. Pullarkat ST, Vardiman JW, Slovak ML, Rao DS, Rao NP, Bedell V, Said JW. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Leuk Res. 2008 Nov; 32(11):1770-5. PMID: 18417213.
      View in: PubMed
    33. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008 Jan; 22(1):14-22. PMID: 17882280.
      View in: PubMed
    34. Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellanné-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood. 2007 Sep 01; 110(5):1648-55. PMID: 17494858.
      View in: PubMed
    35. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, Barosi G, Verstovsek S, Birgegard G, Mesa R, Reilly JT, Gisslinger H, Vannucchi AM, Cervantes F, Finazzi G, Hoffman R, Gilliland DG, Bloomfield CD, Vardiman JW. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007 Aug 15; 110(4):1092-7. PMID: 17488875.
      View in: PubMed
    36. Tefferi A, Vardiman JW. The diagnostic interface between histology and molecular tests in myeloproliferative disorders. Curr Opin Hematol. 2007 Mar; 14(2):115-22. PMID: 17255788.
      View in: PubMed
    37. Singh ZN, Huo D, Anastasi J, Smith SM, Karrison T, Le Beau MM, Larson RA, Vardiman JW. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol. 2007 Feb; 127(2):197-205. PMID: 17210514.
      View in: PubMed
    38. Mesa RA, Verstovsek S, Cervantes F, Barosi G, Reilly JT, Dupriez B, Levine R, Le Bousse-Kerdiles MC, Wadleigh M, Campbell PJ, Silver RT, Vannucchi AM, Deeg HJ, Gisslinger H, Thomas D, Odenike O, Solberg LA, Gotlib J, Hexner E, Nimer SD, Kantarjian H, Orazi A, Vardiman JW, Thiele J, Tefferi A. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res. 2007 Jun; 31(6):737-40. PMID: 17210175.
      View in: PubMed
    39. Paschka P, Marcucci G, Ruppert AS, Mrózek K, Chen H, Kittles RA, Vukosavljevic T, Perrotti D, Vardiman JW, Carroll AJ, Kolitz JE, Larson RA, Bloomfield CD. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol. 2006 Aug 20; 24(24):3904-11. PMID: 16921041.
      View in: PubMed
    40. Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NC, Gilliland DG, Kantarjian H. International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT). Blood. 2006 Sep 01; 108(5):1497-503. PMID: 16675707.
      View in: PubMed
    41. Radmacher MD, Marcucci G, Ruppert AS, Mrózek K, Whitman SP, Vardiman JW, Paschka P, Vukosavljevic T, Baldus CD, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood. 2006 Sep 01; 108(5):1677-83. PMID: 16670265.
      View in: PubMed
    42. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood. 2006 Jul 01; 108(1):63-73. PMID: 16522815.
      View in: PubMed
    43. Thiele J, Kvasnicka HM, Vardiman J. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl. Best Pract Res Clin Haematol. 2006; 19(3):413-37. PMID: 16781481.
      View in: PubMed
    44. Vardiman JW. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2006; 199-204. PMID: 17124061.
      View in: PubMed
    45. Marcucci G, Baldus CD, Ruppert AS, Radmacher MD, Mrózek K, Whitman SP, Kolitz JE, Edwards CG, Vardiman JW, Powell BL, Baer MR, Moore JO, Perrotti D, Caligiuri MA, Carroll AJ, Larson RA, de la Chapelle A, Bloomfield CD. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol. 2005 Dec 20; 23(36):9234-42. PMID: 16275934.
      View in: PubMed
    46. Marcucci G, Mrózek K, Ruppert AS, Maharry K, Kolitz JE, Moore JO, Mayer RJ, Pettenati MJ, Powell BL, Edwards CG, Sterling LJ, Vardiman JW, Schiffer CA, Carroll AJ, Larson RA, Bloomfield CD. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol. 2005 Aug 20; 23(24):5705-17. PMID: 16110030.
      View in: PubMed
    47. Farag SS, Ruppert AS, Mrózek K, Mayer RJ, Stone RM, Carroll AJ, Powell BL, Moore JO, Pettenati MJ, Koduru PR, Stamberg J, Baer MR, Block AW, Vardiman JW, Kolitz JE, Schiffer CA, Larson RA, Bloomfield CD. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. J Clin Oncol. 2005 Jan 20; 23(3):482-93. PMID: 15534356.
      View in: PubMed
    48. Kolitz JE, George SL, Dodge RK, Hurd DD, Powell BL, Allen SL, Velez-Garcia E, Moore JO, Shea TC, Hoke E, Caligiuri MA, Vardiman JW, Bloomfield CD, Larson RA. Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621. J Clin Oncol. 2004 Nov 01; 22(21):4290-301. PMID: 15514371.
      View in: PubMed
    49. Thiele J, Kvasnicka HM, Zerhusen G, Vardiman J, Diehl V, Luebbert M, Schmitt-Graeff A. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol. 2004 Aug; 83(8):513-21. PMID: 15173958.
      View in: PubMed
    50. Rizzieri DA, Johnson JL, Niedzwiecki D, Lee EJ, Vardiman JW, Powell BL, Barcos M, Bloomfield CD, Schiffer CA, Peterson BA, Canellos GP, Larson RA. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer. 2004 Apr 01; 100(7):1438-48. PMID: 15042678.
      View in: PubMed
    51. Sekeres MA, Peterson B, Dodge RK, Mayer RJ, Moore JO, Lee EJ, Kolitz J, Baer MR, Schiffer CA, Carroll AJ, Vardiman JW, Davey FR, Bloomfield CD, Larson RA, Stone RM. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood. 2004 Jun 01; 103(11):4036-42. PMID: 14976037.
      View in: PubMed
    52. Wetzler M, Dodge RK, Mrózek K, Stewart CC, Carroll AJ, Tantravahi R, Vardiman JW, Larson RA, Bloomfield CD. Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. Br J Haematol. 2004 Feb; 124(3):275-88. PMID: 14717774.
      View in: PubMed
    53. List AF, Vardiman J, Issa JP, DeWitte TM. Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program. 2004; 297-317. PMID: 15561689.
      View in: PubMed
    54. Bloomfield CD, Ruppert AS, Mrózek K, Kolitz JE, Moore JO, Mayer RJ, Edwards CG, Sterling LJ, Vardiman JW, Carroll AJ, Pettenati MJ, Stamberg J, Byrd JC, Marcucci G, Larson RA. Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461. Ann Hematol. 2004; 83 Suppl 1:S84-5. PMID: 15124687.
      View in: PubMed
    55. Vardiman JW. Myelodysplastic/myeloproliferative diseases. Cancer Treat Res. 2004; 121:13-43. PMID: 15217205.
      View in: PubMed
    56. Ley TJ, Minx PJ, Walter MJ, Ries RE, Sun H, McLellan M, DiPersio JF, Link DC, Tomasson MH, Graubert TA, McLeod H, Khoury H, Watson M, Shannon W, Trinkaus K, Heath S, Vardiman JW, Caligiuri MA, Bloomfield CD, Milbrandt JD, Mardis ER, Wilson RK. A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14275-80. PMID: 14614138.
      View in: PubMed
    57. Vardiman JW. Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases. Semin Diagn Pathol. 2003 Aug; 20(3):154-79. PMID: 14552429.
      View in: PubMed
    58. Baldus CD, Tanner SM, Ruppert AS, Whitman SP, Archer KJ, Marcucci G, Caligiuri MA, Carroll AJ, Vardiman JW, Powell BL, Allen SL, Moore JO, Larson RA, Kolitz JE, de la Chapelle A, Bloomfield CD. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood. 2003 Sep 01; 102(5):1613-8. PMID: 12750167.
      View in: PubMed
    59. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003 Jul 01; 102(1):43-52. PMID: 12623843.
      View in: PubMed
    60. Byrd JC, Peterson B, Piro L, Saven A, Vardiman JW, Larson RA, Schiffer C. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211. Leukemia. 2003 Feb; 17(2):323-7. PMID: 12592330.
      View in: PubMed
    61. Vardiman JW. The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD. Clin Adv Hematol Oncol. 2003 Jan; 1(1):18, 21. PMID: 16227955.
      View in: PubMed
    62. Farag SS, Archer KJ, Mrózek K, Vardiman JW, Carroll AJ, Pettenati MJ, Moore JO, Kolitz JE, Mayer RJ, Stone RM, Larson RA, Bloomfield CD. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Int J Oncol. 2002 Nov; 21(5):1041-51. PMID: 12370753.
      View in: PubMed
    63. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002 Oct 01; 100(7):2292-302. PMID: 12239137.
      View in: PubMed
    64. Byrd JC, Peterson BL, Morrison VA, Park K, Jacobson R, Hoke E, Vardiman JW, Rai K, Schiffer CA, Larson RA. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood. 2003 Jan 01; 101(1):6-14. PMID: 12393429.
      View in: PubMed
    65. Bennett JM, Brunning RD, Vardiman JW. Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary. Blood. 2002 Apr 15; 99(8):3074-5. PMID: 11949634.
      View in: PubMed
    66. Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, Carroll AJ, Mrózek K, Vardiman JW, George SL, Kolitz JE, Larson RA, Bloomfield CD, Caligiuri MA. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res. 2001 Oct 01; 61(19):7233-9. PMID: 11585760.
      View in: PubMed
    67. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001 Jul; 25(7):603-25. PMID: 11377686.
      View in: PubMed
    68. Mrózek K, Prior TW, Edwards C, Marcucci G, Carroll AJ, Snyder PJ, Koduru PR, Theil KS, Pettenati MJ, Archer KJ, Caligiuri MA, Vardiman JW, Kolitz JE, Larson RA, Bloomfield CD. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol. 2001 May 01; 19(9):2482-92. PMID: 11331327.
      View in: PubMed
    69. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000 Feb; 13(2):193-207. PMID: 10697278.
      View in: PubMed
    70. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology. 2000 Jan; 36(1):69-86. PMID: 10632755.
      View in: PubMed
    71. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J. 2000; 1(1):53-66. PMID: 11920170.
      View in: PubMed
    72. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000; 11 Suppl 1:3-10. PMID: 10707771.
      View in: PubMed
    73. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999 Dec; 17(12):3835-49. PMID: 10577857.
      View in: PubMed
    74. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999 Dec; 10(12):1419-32. PMID: 10643532.
      View in: PubMed
    75. Jaffe ES, Diebold J, Harris NL, Muller-Hermelink HK, Flandrin G, Vardiman JW. Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Blood. 1999 Feb 01; 93(3):1124. PMID: 10025990.
      View in: PubMed
    76. Koeppen H, Vardiman JW. New entities, issues, and controversies in the classification of malignant lymphoma. Semin Oncol. 1998 Aug; 25(4):421-34. PMID: 9728593.
      View in: PubMed
    77. Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer. 1998 May; 22(1):72-8. PMID: 9591637.
      View in: PubMed
    78. Koeppen H, Newell K, Baunoch DA, Vardiman JW. Morphologic bone marrow changes in patients with posttransplantation lymphoproliferative disorders. Am J Surg Pathol. 1998 Feb; 22(2):208-14. PMID: 9500222.
      View in: PubMed
    79. Anastasi J, Musvee T, Roulston D, Domer PH, Larson RA, Vardiman JW. Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive. Leukemia. 1998 Feb; 12(2):233-7. PMID: 9519787.
      View in: PubMed
    80. Hellström-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J, Ost A, Greenberg P. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol. 1997 Nov; 99(2):344-51. PMID: 9375752.
      View in: PubMed
    81. Larson RA, LeBeau MM, Vardiman JW, Rowley JD. Myeloid leukemia after hematotoxins. Environ Health Perspect. 1996 Dec; 104 Suppl 6:1303-7. PMID: 9118910.
      View in: PubMed
    82. Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, Greenberg PL. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood. 1996 May 15; 87(10):4076-81. PMID: 8639764.
      View in: PubMed
    83. Anastasi J, Feng J, Dickstein JI, Le Beau MM, Rubin CM, Larson RA, Rowley JD, Vardiman JW. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia. Leukemia. 1996 May; 10(5):795-802. PMID: 8656674.
      View in: PubMed
    84. Rosati S, Anastasi J, Vardiman J. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Semin Hematol. 1996 Apr; 33(2):111-26. PMID: 8722682.
      View in: PubMed
    85. Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia. 1996 Jan; 10(1):20-6. PMID: 8558932.
      View in: PubMed
    86. Dickstein JI, Vardiman JW. Hematopathologic findings in the myeloproliferative disorders. Semin Oncol. 1995 Aug; 22(4):355-73. PMID: 7638633.
      View in: PubMed
    87. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia. 1995 Apr; 9(4):628-33. PMID: 7723396.
      View in: PubMed
    88. Weisenberg E, Anastasi J, Adeyanju M, Variakojis D, Vardiman JW. Hodgkin's disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type. Am J Clin Pathol. 1995 Apr; 103(4):479-84. PMID: 7726147.
      View in: PubMed
    89. Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R, Murphy SB, Vardiman JW, Larson RA, Le Beau MM, et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia. 1995 Jan; 9(1):95-101. PMID: 7845034.
      View in: PubMed
    90. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia. 1994 Sep; 8(9):1533-8. PMID: 7522291.
      View in: PubMed
    91. Platanias LC, Ratain MJ, O'Brien S, Larson RA, Vardiman JW, Shaw JP, Williams SF, Baron JM, Parker K, Woodworth TG. Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies. Leuk Lymphoma. 1994 Jul; 14(3-4):257-62. PMID: 7950914.
      View in: PubMed
    92. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman JW. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8. PMID: 8180388.
      View in: PubMed
    93. Betman HF, Vardiman JW, Lau J. T-cell-rich B-cell lymphoma of the spleen. Am J Surg Pathol. 1994 Mar; 18(3):323-4. PMID: 8166840.
      View in: PubMed
    94. Chan WC, Hooper C, Wickert R, Benson JM, Vardiman J, Hinrichs S, Weisenburger D. HTLV-I sequence in lymphoproliferative disorders. Diagn Mol Pathol. 1993 Sep; 2(3):192-9. PMID: 8287232.
      View in: PubMed
    95. Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood. 1993 Aug 01; 82(3):737-43. PMID: 7687889.
      View in: PubMed
    96. Dickstein JI, Vardiman JW. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am J Clin Pathol. 1993 Apr; 99(4):513-25. PMID: 8475918.
      View in: PubMed
    97. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood. 1993 Mar 15; 81(6):1580-5. PMID: 8453104.
      View in: PubMed
    98. Spielberger RT, Dickstein JI, Le Beau MM, Larson RA, Daly KM, Vardiman JW, Golomb HM. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol. 1993 Mar; 83(3):519-20. PMID: 8485059.
      View in: PubMed
    99. Olopade OI, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR, Le Beau MM, Vardiman JW, Rowley JD. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 1992 Dec 01; 80(11):2873-82. PMID: 1450412.
      View in: PubMed
    100. Gradishar WJ, Le Beau MM, O'Laughlin R, Vardiman JW, Larson RA. Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia. Blood. 1992 Nov 15; 80(10):2463-70. PMID: 1421369.
      View in: PubMed
    101. Platanias LC, Pfeffer LM, Barton KP, Vardiman JW, Golomb HM, Colamonici OR. Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6. PMID: 1486034.
      View in: PubMed
    102. Kampmeier P, Anastasi J, Vardiman JW. Issues in the pathology of the myelodysplastic syndromes. Hematol Oncol Clin North Am. 1992 Jun; 6(3):501-22. PMID: 1613003.
      View in: PubMed
    103. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood. 1992 Apr 01; 79(7):1796-801. PMID: 1558972.
      View in: PubMed
    104. Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood. 1992 Mar 15; 79(6):1501-10. PMID: 1347709.
      View in: PubMed
    105. Hruban Z, Vardiman J, Meehan T, Frye F, Carter WE. Haematopoietic malignancies in zoo animals. J Comp Pathol. 1992 Jan; 106(1):15-24. PMID: 1556254.
      View in: PubMed
    106. Preisler HD, Larson RA, Raza A, Browman G, Goldberg J, Vogler R, Day R, Gottlieb A, Vardiman JW, Bennett J, et al. The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure. Br J Haematol. 1991 Nov; 79(3):390-7. PMID: 1751366.
      View in: PubMed
    107. Anastasi J, Vardiman JW, Rudinsky R, Patel M, Nachman J, Rubin CM, Le Beau MM. Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: an analysis of suspicious cells in bone marrow specimens of two patients completing therapy for acute lymphoblastic leukemia. Blood. 1991 Jun 01; 77(11):2456-62. PMID: 2039828.
      View in: PubMed
    108. Heimann PS, Vardiman JW, Stock W, Platanias LC, Golomb HM. CD5+, CD11c+, CD20+ hairy cell leukemia. Blood. 1991 Apr 01; 77(7):1617-9. PMID: 1706957.
      View in: PubMed
    109. Moormeier JA, Rubin CM, Le Beau MM, Vardiman JW, Larson RA, Winter JN. Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia. Blood. 1991 Mar 15; 77(6):1397-8. PMID: 2001462.
      View in: PubMed
    110. Anastasi J, Thangavelu M, Vardiman JW, Hooberman AL, Bian ML, Larson RA, Le Beau MM. Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation. Blood. 1991 Mar 01; 77(5):1087-91. PMID: 1995094.
      View in: PubMed
    111. Golomb HM, Fefer A, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem E, Spiegel R, Tensen L, Burke JS, Vardiman JW. Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B. Leuk Lymphoma. 1991; 4(2):99-102. PMID: 27462938.
      View in: PubMed
    112. Moormeier JA, Neilly ME, Vardiman JW, Le Beau MM, Golomb HM. Familial Lymphoproliferative Disorders with Chromosomal Fragile Site Analysis. Leuk Lymphoma. 1991; 5(5-6):311-6. PMID: 27463340.
      View in: PubMed
    113. Rubin CM, Larson RA, Anastasi J, Winter JN, Thangavelu M, Vardiman JW, Rowley JD, Le Beau MM. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 1990 Dec 15; 76(12):2594-8. PMID: 2265251.
      View in: PubMed
    114. Platanias LC, Larson RA, Vardiman JW, Reisel H, Golomb HM, McKeithan TW. Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression. Leukemia. 1990 Dec; 4(12):863-5. PMID: 2173805.
      View in: PubMed
    115. Richards JM, Mick R, Latta JM, Daly K, Ratain MJ, Vardiman JW, Golomb HM. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5. PMID: 1700727.
      View in: PubMed
    116. Thangavelu M, Olopade O, Beckman E, Vardiman JW, Larson RA, McKeithan TW, Le Beau MM, Rowley JD. Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11). Genes Chromosomes Cancer. 1990 Jul; 2(2):147-58. PMID: 2278969.
      View in: PubMed
    117. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol. 1990 Apr; 14(4):305-16. PMID: 2157342.
      View in: PubMed
    118. Anastasi J, Le Beau MM, Vardiman JW, Westbrook CA. Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe. Am J Pathol. 1990 Jan; 136(1):131-9. PMID: 2297044.
      View in: PubMed
    119. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia. 1989 Dec; 3(12):866-70. PMID: 2555633.
      View in: PubMed
    120. Moormeier JA, Ratain MJ, Westbrook CA, Vardiman JW, Daly KM, Golomb HM. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4. PMID: 2746669.
      View in: PubMed
    121. Anastasi J, Bitter MA, Vardiman JW. The histopathologic diagnosis and subclassification of Hodgkin's disease. Hematol Oncol Clin North Am. 1989 Jun; 3(2):187-204. PMID: 2663822.
      View in: PubMed
    122. Bird ML, Ueshima Y, Rowley JD, Haren JM, Vardiman JW. Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia. 1989 Mar; 3(3):182-91. PMID: 2918755.
      View in: PubMed
    123. Ratain MJ, Vardiman JW, Barker CM, Golomb HM. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4. PMID: 3179961.
      View in: PubMed
    124. Ratain MJ, Golomb HM, Vardiman JW, Westbrook CA, Barker C, Hooberman A, Bitter MA, Daly K. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21. PMID: 3054003.
      View in: PubMed
    125. Li YS, Anastasi J, Larson RA, Le Beau MM, Vardiman JW, Rowley JD. A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1988 Oct 15; 35(2):143-50. PMID: 3180017.
      View in: PubMed
    126. Larson RA, Wernli M, Le Beau MM, Daly KM, Pape LH, Rowley JD, Vardiman JW. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood. 1988 Oct; 72(4):1333-9. PMID: 3167210.
      View in: PubMed
    127. Vardiman JW, Gilewski TA, Ratain MJ, Bitter MA, Bradlow BA, Golomb HM. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am J Clin Pathol. 1988 Sep; 90(3):250-6. PMID: 2458031.
      View in: PubMed
    128. Paoletti M, Bitter MA, Vardiman JW. Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features. Clin Lab Med. 1988 Mar; 8(1):179-95. PMID: 3282758.
      View in: PubMed
    129. Samuels BL, Larson RA, Le Beau MM, Daly KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Golomb HM. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83. PMID: 3343866.
      View in: PubMed
    130. Ratain MJ, Kaminer LS, Bitran JD, Larson RA, Le Beau MM, Skosey C, Purl S, Hoffman PC, Wade J, Vardiman JW, et al. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood. 1987 Nov; 70(5):1412-7. PMID: 2822173.
      View in: PubMed
    131. Bitter MA, Nachman J, Jones N, Franklin WA, Le Beau MM, Vardiman JW. Nonlymphoblastic T-cell lymphoma in children. Cancer. 1987 Jun 15; 59(12):2099-103. PMID: 3494500.
      View in: PubMed
    132. Bardawil RG, Ratain MJ, Golomb HM, Bitter MA, Groves C, Vardiman JW. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3. PMID: 3669760.
      View in: PubMed
    133. Bitter MA, Le Beau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol. 1987 Mar; 18(3):211-25. PMID: 3546071.
      View in: PubMed
    134. Ratain MJ, Golomb HM, Bardawil RG, Vardiman JW, Westbrook CA, Kaminer LS, Lembersky BC, Bitter MA, Daly K. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7. PMID: 3814819.
      View in: PubMed
    135. Larson RA, Williams SF, Le Beau MM, Bitter MA, Vardiman JW, Rowley JD. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood. 1986 Dec; 68(6):1242-9. PMID: 3465376.
      View in: PubMed
    136. Ratain MJ, Vardiman JW, Golomb HM. The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8. PMID: 3532332.
      View in: PubMed
    137. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 1986 Jun; 67(6):1765-72. PMID: 3708160.
      View in: PubMed
    138. Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J, Portlock C, Ratain M, Golde D, Vardiman J, Burke JS, et al. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5. PMID: 3519880.
      View in: PubMed
    139. Bennett C, Vardiman J, Golomb H. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6. PMID: 3706377.
      View in: PubMed
    140. Miller-Catchpole R, Variakojis D, Vardiman JW, Loew JM, Carter J. Cat scratch disease. Identification of bacteria in seven cases of lymphadenitis. Am J Surg Pathol. 1986 Apr; 10(4):276-81. PMID: 2422962.
      View in: PubMed
    141. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45. PMID: 3950675.
      View in: PubMed
    142. Bardawil RG, Groves C, Ratain MJ, Golomb HM, Vardiman JW. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201. PMID: 3946302.
      View in: PubMed
    143. Golomb HM, Ratain MJ, Vardiman JW. Sequential treatment of hairy cell leukemia: a new role for interferon. Important Adv Oncol. 1986; 311-21. PMID: 2454218.
      View in: PubMed
    144. Golomb H, Strehl S, Oleske D, Vardiman J. Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist? Blood. 1985 Dec; 66(6):1358-61. PMID: 3933594.
      View in: PubMed
    145. Ueshima Y, Bird ML, Vardiman JW, Rowley JD. A 14;19 translocation in B-cell chronic lymphocytic leukemia: a new recurring chromosome aberration. Int J Cancer. 1985 Sep 15; 36(3):287-90. PMID: 3875568.
      View in: PubMed
    146. Pugh WC, Pearson M, Vardiman JW, Rowley JD. Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment. Br J Haematol. 1985 Jul; 60(3):457-67. PMID: 3860249.
      View in: PubMed
    147. Pearson MG, Vardiman JW, Le Beau MM, Rowley JD, Schwartz S, Kerman SL, Cohen MM, Fleischman EW, Prigogina EL. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. Am J Hematol. 1985 Apr; 18(4):393-403. PMID: 3976650.
      View in: PubMed
    148. Ratain MJ, Golomb HM, Vardiman JW, Vokes EE, Jacobs RH, Daly K. Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8. PMID: 3971043.
      View in: PubMed
    149. Vardiman JW, Golomb HM. Autopsy findings in hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4):370-80. PMID: 6505704.
      View in: PubMed
    150. Golomb HM, Schmidt K, Vardiman JW. Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4 Suppl 2):502-8. PMID: 6505712.
      View in: PubMed
    151. Prystowsky MB, Otten G, Naujokas MF, Vardiman J, Ihle JN, Goldwasser E, Fitch FW. Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3. Am J Pathol. 1984 Nov; 117(2):171-9. PMID: 6437231.
      View in: PubMed
    152. Levine LE, Pearson MG, Baron JM, Medenica MM, Vardiman J. Extramedullary hematopoiesis. Arch Dermatol. 1984 Oct; 120(10):1282. PMID: 6486842.
      View in: PubMed
    153. Newman SB, Sweet DL, Vardiman JW. Sinus histiocytosis with massive lymphadenopathy: response to cyclophosphamide therapy. Cancer Treat Rep. 1984 Jun; 68(6):901-2. PMID: 6733703.
      View in: PubMed
    154. Bitter MA, Le Beau MM, Larson RA, Rosner MC, Golomb HM, Rowley JD, Vardiman JW. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984 Jun; 81(6):733-41. PMID: 6203400.
      View in: PubMed
    155. Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May; 76(5):827-41. PMID: 6586073.
      View in: PubMed
    156. Vardiman J, Catovsky D, Flandrin GR, Pierre R. Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation between morphology and karyotype. Cancer Genet Cytogenet. 1984 Mar; 11(3):275-81. PMID: 6704930.
      View in: PubMed
    157. Jacobs RH, Larson RA, LeBeau M, Kluskens LF, Vardiman JW, Rowley JD, Golomb HM. Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. N Engl J Med. 1984 Jan 26; 310(4):263-4. PMID: 6318111.
      View in: PubMed
    158. Larson RA, Le Beau MM, Vardiman JW, Testa JR, Golomb HM, Rowley JD. The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36. PMID: 6627222.
      View in: PubMed
    159. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983 Sep 15; 309(11):630-6. PMID: 6577285.
      View in: PubMed
    160. Vardiman JW, Coelho A, Golomb HM, Rowley J. Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol. 1983 May; 79(5):525-30. PMID: 6188364.
      View in: PubMed
    161. Golomb HM, Vardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983 Feb; 61(2):349-52. PMID: 6821700.
      View in: PubMed
    162. Albain KS, Le Beau MM, Vardiman JW, Golomb HM, Rowley JD. Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet Cytogenet. 1983 Feb; 8(2):107-15. PMID: 6825062.
      View in: PubMed
    163. Bitran JD, Sweet DL, Vardiman J, Golomb HM, Ultmann JE. Histiocytic lymphoma: response to chemotherapy. Ann Intern Med. 1982 Oct; 97(4):617-8. PMID: 6751185.
      View in: PubMed
    164. Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug; 60(2):404-11. PMID: 7093525.
      View in: PubMed
    165. Golomb HM, Davis S, Wilson C, Vardiman J. Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia. Am J Hematol. 1982 Jun; 12(4):397-401. PMID: 7114052.
      View in: PubMed
    166. Wong KK, Golomb HM, Rowley J, Baker AL, Testa J, Vardiman J. Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92. PMID: 6807532.
      View in: PubMed
    167. Butler AE, Vardiman JW, Golomb HM. Ultrastructural characterization of de novo and secondary leukemias. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 39(3):239-57. PMID: 6126030.
      View in: PubMed
    168. Leyser S, Variakojis D, Mintz U, Vardiman JW, Ultmann JE. Multiple histologic subtypes of non-Hodgkin's lymphoma: clinical and pathologic features. Cancer. 1981 Nov 01; 48(9):2063-9. PMID: 7296513.
      View in: PubMed
    169. Ramseur WL, Golomb HM, Vardiman JW, Oleske D, Collins JL. Hairy cell leukemia in father and son. Cancer. 1981 Oct 15; 48(8):1825-9. PMID: 7284978.
      View in: PubMed
    170. Rowley JD, Golomb HM, Vardiman JW. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67. PMID: 7272506.
      View in: PubMed
    171. Gaeke ME, Vardiman JW, Miller W, Medenica M, Hopper JE, Rowley JD. Human T-cell lymphoma with suppressor effects on the mixed lymphocyte reaction (MLR). I. Morphological and cytogenetic analysis. Blood. 1981 Apr; 57(4):634-41. PMID: 6451247.
      View in: PubMed
    172. Check IJ, Hunter RL, Karrison T, DeMeester TR, Golomb HM, Vardiman J. Prognostic significance of immunological tests in lung cancer. Clin Exp Immunol. 1981 Feb; 43(2):362-9. PMID: 7023761.
      View in: PubMed
    173. Testa JR, Kanofsky JR, Rowley JD, Baron JM, Vardiman JW. Karyotypic patterns and their clinical significance in polycythemia vera. Am J Hematol. 1981; 11(1):29-45. PMID: 6943932.
      View in: PubMed
    174. Golomb HM, Mintz U, Vardiman J, Wilson C, Rosner MC. Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia. Cancer. 1980 Jul 01; 46(1):50-5. PMID: 6770992.
      View in: PubMed
    175. Streuli RA, Testa JR, Vardiman JW, Mintz U, Golomb HM, Rowley JD. Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood. 1980 Apr; 55(4):636-44. PMID: 6928379.
      View in: PubMed
    176. Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler A. "Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity. Blood. 1980 Feb; 55(2):253-9. PMID: 6928105.
      View in: PubMed
    177. Variakojis D, Vardiman JW, Golomb HM. Cytochemistry of hairy cells. Cancer. 1980 Jan 01; 45(1):72-7. PMID: 7351007.
      View in: PubMed
    178. Testa JR, Mintz U, Rowley JD, Vardiman JW, Golomb HM. Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 1979 Sep; 39(9):3619-27. PMID: 476688.
      View in: PubMed
    179. Golomb HM, Vardiman J, Variakojis D. Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: cytochemical, functional, and clinical correlations. Br J Haematol. 1979 Sep; 43(1):156-7. PMID: 508618.
      View in: PubMed
    180. Vardiman JW, Variakojis D, Golomb HM. Hairy cell leukemia: an autopsy study. Cancer. 1979 Apr; 43(4):1339-49. PMID: 445334.
      View in: PubMed
    181. Mintz U, Vardiman J, Golomb HM, Rowley JD. Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia. Cancer. 1979 Feb; 43(2):411-6. PMID: 283874.
      View in: PubMed
    182. Check IJ, DeMeester T, Vardiman J, Hunter RL. Differential counts and survival in lung cancer. Lancet. 1978 Dec 16; 2(8103):1317-8. PMID: 82829.
      View in: PubMed
    183. Golomb HM, Vardiman JW, Rowley JD, Testa JR, Mintz U. Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med. 1978 Sep 21; 299(12):613-9. PMID: 79982.
      View in: PubMed
    184. Golomb HM, Vardiman J. Hairy cell leukemia: diagnosis and management. CA Cancer J Clin. 1978 Sep-Oct; 28(5):265-77. PMID: 100187.
      View in: PubMed
    185. Testa JR, Golomb HM, Rowley JD, Vardiman JW, Sweet DL. Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. Blood. 1978 Aug; 52(2):272-80. PMID: 276386.
      View in: PubMed
    186. Vardiman JW, Golomb HM, Rowley JD, Variakojis D. Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42. PMID: 276415.
      View in: PubMed
    187. Golomb HM, Vardiman J, Sweet DL, Simon D, Variakojis D. Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb; 38(2):161-70. PMID: 638066.
      View in: PubMed
    188. Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C, Potter D. Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer. 1977 Dec 15; 20(6):869-72. PMID: 271143.
      View in: PubMed
    189. Rowley JD, Golomb HM, Vardiman J. Acute leukemia after treatment of lymphoma. N Engl J Med. 1977 Nov 03; 297(18):1013. PMID: 909537.
      View in: PubMed
    190. Desser RK, Golomb HM, Ultmann JE, Ferguson DJ, Moran EM, Griem ML, Vardiman J, Miller B, Oetzel N, Sweet D, Lester EP, Kinzie JJ, Blough R. Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood. 1977 Jun; 49(6):883-93. PMID: 861375.
      View in: PubMed
    191. Golomb HM, Vardiman J, Rowley JD. Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul; 48(1):9-21. PMID: 59614.
      View in: PubMed
    192. Golomb HM, Rowley J, Vardiman J, Baron J, Locker G, Krasnow S. Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Arch Intern Med. 1976 Jul; 136(7):825-8. PMID: 1065255.
      View in: PubMed
    193. Vardiman JW, Byrne GE, Rappaport H. Malignant histiocytosis with massive splenomegaly in asymptomatic patients. A possible chronic form of the disease. Cancer. 1975 Aug; 36(2):419-27. PMID: 1157011.
      View in: PubMed
    194. Patt DJ, Brynes RK, Vardiman JW, Coppleson LW. Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: an immunomorphologic study. Cancer. 1975 May; 35(5):1388-96. PMID: 1122487.
      View in: PubMed
    Vardiman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _